InsiderTrades

Form 4 for EYPT EyePoint, Inc.

Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-02 · accession 0001562180-24-001050 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DT 2024-02-05 2024-02-02 EYPT Jones David Scott SVP, Chief Commercial Off M - OptEx $11.47 +209 38.2K +0.6% +$2,397
DT 2024-02-05 2024-02-02 EYPT Jones David Scott SVP, Chief Commercial Off S - Sale+OE $28.49 -209 38.0K -0.5% -$5,954
DT 2024-02-05 2024-02-02 EYPT Jones David Scott SVP, Chief Commercial Off M - OptEx $0.00 -209 4,375 -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-02 M A 209 $11.47 38,171 D — —
2 Common Common Stock 2024-02-02 S D 209 $28.49 37,962 D — —
3 Derivative Stock Option (Right to Buy) 2024-02-02 M D 209 $0.00 4,375 D $11.47 · — to 2031-11-01 209 Common Stock (F1) The option to purchase vests and becomes exercisable as follows: 25% at November 1st, 2022 and the remainder ratably, on a monthly basis, over the remaining three years.